| Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone TM Schmidt, BG Barwick, N Joseph, LT Heffner, CC Hofmeister, L Bernal, ... Blood Cancer Journal 9 (12), 94, 2019 | 153 | 2019 |
| 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label … AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, ... The Lancet 397 (10288), 1895-1904, 2021 | 126 | 2021 |
| Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers M Yarchoan, L Cope, AN Ruggieri, RA Anders, AM Noonan, LW Goff, ... The Journal of Clinical Investigation 131 (24), 2021 | 51 | 2021 |
| Immune-related adverse events as clinical biomarkers in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, ... The Oncologist 26 (10), e1742-e1750, 2021 | 25 | 2021 |
| Immune-related adverse events as clinical biomarkers in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, ... The Oncologist 26 (10), e1742-e1750, 2021 | 25 | 2021 |
| Mismatch Repair (MMR) gene alteration and BRAF V600E mutation are potential predictive biomarkers of immune checkpoint inhibitors in MMR-deficient colorectal cancer IH Sahin, S Goyal, Y Pumpalova, MB Sonbol, S Das, S Haraldsdottir, ... The oncologist 26 (8), 668-675, 2021 | 25 | 2021 |
| Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy DA Bond, JM Switchenko, D Villa, K Maddocks, M Churnetski, AS Gerrie, ... Blood Advances 5 (23), 5179-5189, 2021 | 24 | 2021 |
| Body composition variables as radiographic biomarkers of clinical outcomes in metastatic renal cell carcinoma patients receiving immune checkpoint inhibitors DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, ... Frontiers in Oncology 11, 707050, 2021 | 24 | 2021 |
| Body composition as an independent predictive and prognostic biomarker in advanced urothelial carcinoma patients treated with immune checkpoint inhibitors DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, ... The Oncologist 26 (12), 1017-1025, 2021 | 19 | 2021 |
| Multi‐center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era R Karmali, JM Switchenko, S Goyal, K Shanmugasundaram, ... American journal of hematology 96 (11), 1374-1384, 2021 | 17 | 2021 |
| Intellectual functioning among case‐matched cohorts of children treated with proton or photon radiation for standard‐risk medulloblastoma BR Eaton, GW Fong, LM Ingerski, MB Pulsifer, S Goyal, C Zhang, ... Cancer 127 (20), 3840-3846, 2021 | 16 | 2021 |
| Salvage radiotherapy management decisions in postprostatectomy patients with recurrent prostate cancer based on 18f-fluciclovine PET/CT guidance OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, ... Journal of Nuclear Medicine 62 (8), 1089-1096, 2021 | 16 | 2021 |
| Initial Report of a Randomized Trial Comparing Conventional-vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, ... International Journal of Radiation Oncology, Biology, Physics 108 (5), 1397, 2020 | 15 | 2020 |
| Efficacy and safety of immune checkpoint blockade in self‐identified black patients with advanced non–small cell lung cancer B Nazha, S Goyal, Z Chen, A Engelhart, JW Carlisle, TJ Beardslee, H Gill, ... Cancer, 2020 | 15 | 2020 |
| Construct validation and comparison of a novel postoperative quality-of-life metric and the Short Form-36 in colorectal surgery patients DS Keller, MF McGee, S Goyal, T Nobel, BOB Ermlich, VK Cheruvu, ... Surgery 154 (4), 690-696, 2013 | 15 | 2013 |
| MERTK activation drives osimertinib resistance in EGFR-mutant non–small cell lung cancer D Yan, JM Huelse, D Kireev, Z Tan, L Chen, S Goyal, X Wang, SV Frye, ... The Journal of clinical investigation 132 (15), 2022 | 14 | 2022 |
| Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel JT Romancik, S Goyal, JN Gerson, HJ Ballard, Y Sawalha, DA Bond, ... Blood 138, 1756, 2021 | 13 | 2021 |
| Maintenance rituximab improves outcomes in mantle cell lymphoma patients who respond to induction therapy with bendamustine+ rituximab without autologous transplant BT Hill, JM Switchenko, P Martin, MC Churnetski, Y Sawalha, S Goyal, ... Blood 134, 1525, 2019 | 13 | 2019 |
| Regional nodal irradiation for clinically node-positive breast cancer patients with pathologic negative nodes after neoadjuvant chemotherapy A Schlafstein, Y Liu, S Goyal, S Kahn, K Godette, J Lin, MA Torres, ... Clinical breast cancer 22 (2), 127-135, 2022 | 10 | 2022 |
| Outcomes following early relapse in patients with mantle cell lymphoma DA Bond, JM Switchenko, KJ Maddocks, MC Churnetski, S Goyal, ... Blood 134, 753, 2019 | 10 | 2019 |
